CoV-GLUE Lineage

CoV-GLUE Lineage: B.1.1.297

Table of countries and their respective (filtered) sequence count for the lineage 'B.1.1.297'.

Lineage	Country	Count	EarliestEpiWeek	LatestEpiWeek	View Mutations	29	30	31	32	33	34	35	36	37	38	39	40	41	42	43	44	45	46	47	48	49	50	51	52	53	54	55	56	57	58	59	60	61	62	63	64	65	66	67	68	69	70	71	72
B.1.1.297	All	447	29	72	Mutations	1	5	7	15	9	6	5	6	7	20	6	3	11	23	24	29	14	21	10	5	9	9	6	5	1	8	7	21	15	18	22	15	12	14	5	2	2	8	3	8	1	0	3	1
B.1.1.297	GERMANY	190	31	68		0	0	1	0	0	0	0	2	0	1	0	2	3	2	0	7	2	9	2	2	3	5	2	3	1	5	6	19	14	17	20	15	11	14	5	2	2	8	3	2	0	0	0	0
B.1.1.297	BELGIUM	122	29	72		1	5	5	15	4	6	1	1	6	14	4	0	4	6	8	7	1	2	3	0	3	1	3	0	0	3	1	2	1	1	2	0	1	0	0	0	0	0	0	6	1	0	3	1
B.1.1.297	NETHERLANDS	55	31	52		0	0	1	0	1	0	0	0	0	0	2	1	0	10	3	1	2	5	1	0	1	1	0	1	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
B.1.1.297	LUXEMBOURG	48	35	51		0	0	0	0	0	0	1	0	0	0	0	0	1	3	10	12	7	2	4	3	2	2	1	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
B.1.1.297	FRANCE	20	33	46		0	0	0	0	3	0	2	2	1	5	0	0	1	1	1	1	1	2	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
B.1.1.297	SWITZERLAND	5	41	44		0	0	0	0	0	0	0	0	0	0	0	0	1	1	2	1	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
B.1.1.297	SPAIN	2	41	52		0	0	0	0	0	0	0	0	0	0	0	0	1	0	0	0	0	0	0	0	0	0	0	1	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
B.1.1.297	UK-ENGLAND	2	36	46		0	0	0	0	0	0	0	1	0	0	0	0	0	0	0	0	0	1	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
B.1.1.297	RUSSIA	1	35	35		0	0	0	0	0	0	1	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
B.1.1.297	CANADA	1	45	45		0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	1	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
B.1.1.297	ICELAND	1	33	33		0	0	0	0	1	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0

CoV-GLUE is still in development. CoV-GLUE was originally developed as part of COG-UK by Josh Singer using the GLUE framework at the MRC-University of Glasgow Centre for Virus Research (CVR). In 2021 it was redeveloped by Richard Orton to scale to the millions of genome sequences available. We acknowledge support from the MRC (MC_UU_12014/12), WT (220977/Z/20/Z) and UKRI G2P (MR/W005611/1). Please contact Richard Orton with any queries: Richard.Orton@glasgow.ac.uk

CoV-GLUE uses sequence data from GISAID. GISAID data provided via this web application is subject to GISAID's Terms and Conditions.